Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SYK | Common Stock | Sale | -$785K | -2.12K | -17.44% | $370.00 | 10K | Sep 13, 2024 | Direct | F1 |
transaction | SYK | Common Stock | Options Exercise | $900K | +7.35K | +73.16% | $122.51 | 17.4K | Sep 16, 2024 | Direct | |
transaction | SYK | Common Stock | Sale | -$93.2K | -258 | -1.48% | $361.21 | 17.1K | Sep 17, 2024 | Direct | F1, F2 |
transaction | SYK | Common Stock | Sale | -$484K | -1.34K | -7.8% | $362.23 | 15.8K | Sep 17, 2024 | Direct | F1, F3 |
transaction | SYK | Common Stock | Sale | -$172K | -474 | -3% | $363.28 | 15.3K | Sep 17, 2024 | Direct | F1, F4 |
transaction | SYK | Common Stock | Sale | -$232K | -635 | -4.14% | $364.57 | 14.7K | Sep 17, 2024 | Direct | F1, F5 |
transaction | SYK | Common Stock | Sale | -$178K | -487 | -3.32% | $365.31 | 14.2K | Sep 17, 2024 | Direct | F1, F6 |
transaction | SYK | Common Stock | Sale | -$342K | -931 | -6.56% | $367.16 | 13.3K | Sep 17, 2024 | Direct | F1, F7 |
transaction | SYK | Common Stock | Sale | -$169K | -460 | -3.47% | $367.98 | 12.8K | Sep 17, 2024 | Direct | F1, F8 |
transaction | SYK | Common Stock | Sale | -$251K | -680 | -5.31% | $369.05 | 12.1K | Sep 17, 2024 | Direct | F1, F9 |
transaction | SYK | Common Stock | Sale | -$49.7K | -134 | -1.1% | $370.64 | 12K | Sep 17, 2024 | Direct | F1, F10 |
transaction | SYK | Common Stock | Sale | -$569K | -1.53K | -12.76% | $371.58 | 10.5K | Sep 17, 2024 | Direct | F1, F11 |
transaction | SYK | Common Stock | Sale | -$157K | -422 | -4.03% | $372.56 | 10K | Sep 17, 2024 | Direct | F1, F12 |
holding | SYK | Common Stock | 398 | Sep 13, 2024 | By 401K |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SYK | Employee Stock Option granted 02/08/2017 (right to buy) | Options Exercise | $0 | -7.35K | -100% | $0.00 | 0 | Sep 16, 2024 | Common Stock | 7.35K | $122.51 | Direct | F13 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024. |
F2 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.785 to $361.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F3 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.865 to $362.72, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F4 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.84 to $363.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F5 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.215 to $364.92, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F6 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.935 to $365.925, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F7 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.56 to $367.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F8 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.625 to $368.585, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F9 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.735 to $369.645, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F10 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $369.855 to $370.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F11 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $370.87 to $371.87, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F12 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $372.205 to $373.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
F13 | Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |